Clinical outcomes of autologous adipose-derived mesenchymal stem cell combined with high tibial osteotomy for knee osteoarthritis are correlated with stem cell stemness and senescence

Houyi Sun,Haoxin Zhai,Kaifei Han,Heran Ma,Yi Tan,Shihao Li,Zhicheng Liu,Lei Cheng,Qunshan Lu,Libo Zhou,Peilai Liu
DOI: https://doi.org/10.1186/s12967-024-05814-3
IF: 8.44
2024-11-27
Journal of Translational Medicine
Abstract:Mesenchymal stem cells (MSCs) have been proposed to treat osteoarthritis (OA) for many years. However, clinical outcomes have been inconsistent due to biological variation between patients, differences in tissue source and preparation of the MSCs, and type of donor (e.g. allogenic versus autologous). Here, we test the hypothesis that inconsistent clinical outcomes are related to variations in the stemness and senescence of the injected autologous adipose-derived (AD) MSCs.
medicine, research & experimental
What problem does this paper attempt to address?